nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer
|
Sarkar, Reith R. |
|
|
2 |
5 |
p. 584-588 |
artikel |
2 |
A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging
|
Palsdottir, Thorgerdur |
|
|
2 |
5 |
p. 490-496 |
artikel |
3 |
Back to Basics: Addressing Bone Health in Men with Prostate Cancer on Androgen Deprivation Therapy
|
Morgans, Alicia K. |
|
|
2 |
5 |
p. 562-564 |
artikel |
4 |
Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?
|
Grossman, H. Barton |
|
|
2 |
5 |
p. 597-602 |
artikel |
5 |
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non–muscle-invasive Bladder Cancer
|
Racioppi, Marco |
|
|
2 |
5 |
p. 576-583 |
artikel |
6 |
Contents
|
|
|
|
2 |
5 |
p. iii-v |
artikel |
7 |
Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy
|
Patterson, Karl |
|
|
2 |
5 |
p. 565-571 |
artikel |
8 |
Diagnosis and Management of Local Recurrence After Prostate Focal Therapy: Challenges and Solutions
|
Aminsharifi, Alireza |
|
|
2 |
5 |
p. 539-540 |
artikel |
9 |
Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer
|
Huo, Jinhai |
|
|
2 |
5 |
p. 497-504 |
artikel |
10 |
Editorial Board
|
|
|
|
2 |
5 |
p. i-ii |
artikel |
11 |
Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients
|
Soeterik, Timo F.W. |
|
|
2 |
5 |
p. 483-489 |
artikel |
12 |
Is Pelvic Lymph Node Dissection Necessary During Cytoreductive Radical Prostatectomy?
|
Pavlovich, Christian P. |
|
|
2 |
5 |
p. 549-550 |
artikel |
13 |
Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy
|
Hamid, Anis A. |
|
|
2 |
5 |
p. 475-482 |
artikel |
14 |
Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis
|
Joseph, Joseph Sargon |
|
|
2 |
5 |
p. 551-561 |
artikel |
15 |
Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111–28
|
Massari, Francesco |
|
|
2 |
5 |
p. 603-604 |
artikel |
16 |
Salvage Local Treatments After Focal Therapy for Prostate Cancer
|
Marra, Giancarlo |
|
|
2 |
5 |
p. 526-538 |
artikel |
17 |
Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma
|
de Velasco, Guillermo |
|
|
2 |
5 |
p. 505-514 |
artikel |
18 |
Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies
|
Zaorsky, Nicholas G. |
|
|
2 |
5 |
p. 515-523 |
artikel |
19 |
Systematic Review and Pooled Analysis of the Impact of Renorrhaphy Techniques on Renal Functional Outcome After Partial Nephrectomy
|
Bertolo, Riccardo |
|
|
2 |
5 |
p. 572-575 |
artikel |
20 |
The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes
|
Mazzone, Elio |
|
|
2 |
5 |
p. 541-548 |
artikel |
21 |
Using Stereotactic Body Radiotherapy to Overcome the Radioresistant Reputation of Renal Cell Carcinoma
|
Nguyen, Paul L. |
|
|
2 |
5 |
p. 524-525 |
artikel |
22 |
Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery
|
Van den Broeck, Thomas |
|
|
2 |
5 |
p. 589-596 |
artikel |